Pregnancy outcomes in inflammatory skin diseases

被引:1
|
作者
Onan, Duru Tabanlioglu [1 ]
Yorulmaz, Ahu [1 ]
Dikmen, Asiye Ugras [2 ]
Yakut, Kadriye [3 ]
Guler, Ismail [4 ]
Atalay, Cemal Resat [3 ]
Artuz, Refika Ferda [1 ]
Yalcin, Basak [1 ]
机构
[1] Univ Hlth Sci, Ankara Numune Training & Res Hosp, Clin Dermatol, Ankara, Turkey
[2] Gazi Univ, Dept Publ Hlth, Fac Med, Ankara, Turkey
[3] Univ Hlth Sci, Ankara Numune Training & Res Hosp, Clin Obstet & Gynecol, Ankara, Turkey
[4] Gazi Univ, Dept Obstet & Gynecol, Fac Med, Ankara, Turkey
关键词
Inflammation; skin diseases; pregnancy outcome; chronic disease;
D O I
10.4274/turkderm.59260
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Design: Inflammation can lead to adverse outcomes in pregnancy. Some inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and psoriasis, are associated with preterm birth and low birth weight. The objectives of our study were to assess the effect of various inflammatory skin diseases (ISDs) on pregnancy outcomes and to evaluate the course of ISDs during pregnancy. Materials and Methods: In this multicenter cohort study, a total of 242 pregnant women in three groups including 32 pregnants with a history of ISDs, 70 pregnants with a diagnosis of systemic disease and 140 healthy pregnants were prospectively analyzed. Results: The rate of adverse pregnancy outcome was 34.4% in ISDs, 37.1% in systemic diseases and 25% in healthy pregnant groups (p=0.16). Gestational diabetes mellitus (12.5%) and thyroid dysfunction in pregnancy (9.4%) were the most common adverse outcomes of pregnancy seen in ISDs group. The disease course of ISDs was stable in 50%, improved in 28.1% and exacerbated in 21.9% of patients during pregnancy. Conclusion: We could not demonstrate a significant association between ISDs and adverse pregnancy outcomes. Most of the ISDs were either stable or improved during pregnancy.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [41] Inflammatory diseases of the pituitary during pregnancy
    Hansen, I
    Bétéa, D
    Beckers, A
    ANNALES D ENDOCRINOLOGIE, 2002, 63 (05) : 464 - 469
  • [42] Managing pregnancy in inflammatory rheumatological diseases
    Jain, Varsha
    Gordon, Caroline
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (01)
  • [43] Bacterial Metabolites and Inflammatory Skin Diseases
    Jiminez, Victoria
    Yusuf, Nabiha
    METABOLITES, 2023, 13 (08)
  • [44] The cutaneous microbiome in inflammatory skin diseases
    Loser, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 33 - 34
  • [45] Hidden workload of inflammatory skin diseases
    Ho, W. L.
    Ramsay, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 444 - 445
  • [46] Chemokine networks in inflammatory skin diseases
    Pastore, S
    Mascia, F
    Mariotti, F
    Dattilo, C
    Girolomoni, G
    EUROPEAN JOURNAL OF DERMATOLOGY, 2004, 14 (04) : 203 - 208
  • [47] The role of chemokines in inflammatory skin diseases
    Girolomoni, G
    Pastore, S
    Cavani, A
    Albanesi, C
    LEUCOCYTE TRAFFICKING: THE ROLE OF FUCOSYLTRANSFERASES AND SELECTINS, 2004, 44 : 191 - 225
  • [48] Daily Lifestyle and Inflammatory Skin Diseases
    Sawada, Yu
    Saito-Sasaki, Natsuko
    Mashima, Emi
    Nakamura, Motonobu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [49] THE VALUE OF BIOPSY IN INFLAMMATORY SKIN DISEASES
    STEFFEN, C
    AMERICAN FAMILY PHYSICIAN, 1985, 31 (01) : 197 - 198
  • [50] γδ T cells and inflammatory skin diseases
    Jee, Mia Hamilton
    Mraz, Veronika
    Geisler, Carsten
    Bonefeld, Charlotte Menne
    IMMUNOLOGICAL REVIEWS, 2020, 298 (01) : 61 - 73